Nurix Therapeutics Inc.

Last updated September 27, 2026

Favorite this organization

Organization details

Legal name: Nurix Therapeutics Inc.
Former names: Nurix, Inc.
Ownership: Public
Status: Active
Sector (GICS): Health Care
SIC code: 2834 — Pharmaceutical Preparations
Jurisdiction of incorporation: Delaware
Headquarters city: Brisbane
Headquarters state / province: California
Headquarters country: United States
Fiscal year end: November
Ticker symbol: NRIX
Primary stock exchange: Nasdaq

Identifiers

SEC CIK: 0001549595
EIN: 27-0838048
Wikidata ID: Q106411724

Board of directors

Follow this board

Anil Kapur · Director
Since 2024
Arthur T. Sands · Director · President, CEO
Since 2023
David L. Lacey · Director
Since 2023
Edward C. Saltzman · Director
Since 2023
Judith A. Reinsdorf · Director
Since 2023
Julia P. Gregory · Director
Since 2023
Lori Anne Kunkel · Director
Since 2023
Paul M. Silva · Director
Since 2023
Roger D. Dansey · Director
Since 2025
Roy D. Baynes · Director
Since 2025

Chief executives

Arthur T. Sands · President, CEO

Dates unknown

Director election results

Annual meeting of May 15, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

8 of this board's directors also sit on 13 other boards. 11 are in the same sector.

Shared director Other board Same sector

Aardvark Therapeutics Inc. Same sector
via Roy D. Baynes
Arcus Biosciences Inc. Same sector
via David L. Lacey
Bicycle Therapeutics plc Same sector
via Roger D. Dansey
Biohaven Ltd. Same sector
via Julia P. Gregory
Enliven Therapeutics Inc. Same sector
via Lori Anne Kunkel
Enpro Inc.
via Judith A. Reinsdorf
Inovio Pharmaceuticals Inc. Same sector
via Roger D. Dansey
Natera Inc. Same sector
via Roy D. Baynes
Oric Pharmaceuticals Inc. Same sector
via Lori Anne Kunkel
Rapport Therapeutics Inc. Same sector
via Paul M. Silva
Toll Brothers Inc.
via Judith A. Reinsdorf
Travere Therapeutics Inc. Same sector
via Roy D. Baynes
Verastem Inc. Same sector
via Anil Kapur

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months: $0; 0 purchases by 0 insiders
Sold, last 12 months: $5,274,856; 46 sales by 3 insiders

Date	Insider	Transaction	Shares	Price	Value
Nov 4, 2026	van Houte Hans Officer (Chief Financial Officer)	Open-market sale	−3,300	$15.38	$50,762
Nov 4, 2026	van Houte Hans Officer (Chief Financial Officer)	Open-market sale	−1,469	$16.20	$23,800
Nov 3, 2026	Ring Christine Officer (Chief Legal Officer)	Open-market sale	−6,113	$25.83	$157,917
Nov 2, 2026	Ring Christine Officer (Chief Legal Officer)	Option exercise	+5,786	$8.72	$50,454
Nov 2, 2026	Ring Christine Officer (Chief Legal Officer)	Open-market sale	−9,527	$25.74	$245,217
Nov 2, 2026	Ring Christine Officer (Chief Legal Officer)	Open-market sale	−1,075	$26.76	$28,770
Nov 2, 2026	Hansen Gwenn Officer (Chief Scientific Officer)	Option exercise	+1,452	$1.86	$2,701
Nov 2, 2026	Hansen Gwenn Officer (Chief Scientific Officer)	Open-market sale	−1,452	$26.80	$38,914
Oct 30, 2026	Hansen Gwenn Officer (Chief Scientific Officer)	Option exercise	+3,750	—	—
Oct 30, 2026	Ring Christine Officer (Chief Legal Officer)	Option exercise	+3,750	—	—
Oct 30, 2026	van Houte Hans Officer (Chief Financial Officer)	Option exercise	+3,750	—	—
Oct 30, 2026	Hansen Gwenn Officer (Chief Scientific Officer)	Option exercise	+2,859	—	—
Oct 30, 2026	Ring Christine Officer (Chief Legal Officer)	Option exercise	+2,859	—	—
Oct 30, 2026	van Houte Hans Officer (Chief Financial Officer)	Option exercise	+2,859	—	—
Oct 30, 2026	Hansen Gwenn Officer (Chief Scientific Officer)	Option exercise	+3,573	—	—

Peers

Compare boards

Organizations in the same sector, closest in location and size first.

3M Company NYSE: MMM · ST Paul, United States Organization ABVC BioPharma Inc. Nasdaq: ABVC · Fremont, United States Organization ACADIA Pharmaceuticals Inc. Nasdaq: ACAD · SAN Diego, United States Organization ADMA Biologics Inc Nasdaq: ADMA · Ramsey, United States Organization

Questions about Nurix Therapeutics Inc.

Who is the CEO of Nurix Therapeutics Inc.?

Arthur T. Sands is Nurix Therapeutics Inc.'s President, CEO.

How many directors are on Nurix Therapeutics Inc.'s board?

Nurix Therapeutics Inc.'s board has 10 directors: Anil Kapur, Arthur T. Sands, David L. Lacey, Edward C. Saltzman, Judith A. Reinsdorf, Julia P. Gregory, Lori Anne Kunkel, Paul M. Silva, Roger D. Dansey and Roy D. Baynes.

Are Nurix Therapeutics Inc. insiders buying or selling shares?

Over the last 12 months, Nurix Therapeutics Inc. insiders made no open-market purchases and sold $5.3 million of shares in 46 sales on the open market, as reported to the SEC on Forms 4 and 5.

How is Nurix Therapeutics Inc. connected to…? → Spot something wrong? Report a correction

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="nurix-therapeutics-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

No reviews yet. Be the first to write one.